✦ LIBER ✦

Exploring cancer-related genes: Application for molecular target-based therapy and prevention

✍ Scribed by Young-Joon Surh; Yong-Sung Juhnn

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 582 KB
Volume: 50
Category: Article
ISSN: 0899-1987
DOI: 10.1002/mc.20726

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retracted: The evolution of predictive o

Retracted: The evolution of predictive oncology and molecular-based therapy for oral cancer prevention

✍ Jon Sudbø; Albrecht Reith 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 518 KB

## Abstract Retraction: The following article from International Journal of Cancer, “The evolution of predictive oncology and molecular‐based therapy for oral cancer prevention”, by Jon Sudbø and Albrecht Reith, published online in Wiley InterScience (http://www3.interscience.wiley.com) on 1 Februa

Cell cycle: Molecular targets for diagno

Cell cycle: Molecular targets for diagnosis and therapy: Tumor suppressor genes and cell cycle progression in cancer

✍ Antonio Giordano; Youcef M. Rustum; Charles E. Wenner 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 2 views

A significant portion of published literature is dedicated to describing the cloning and the characterization of proteins involved in the progression of the cell cycle, which govern cell growth both in cancer and normal ontogenesis. With this abundance of information, the cascading pathways of molec

Molecular-cytogenetic characterization o

Molecular-cytogenetic characterization of head and neck cancer: Identification of novel prognostic factors and gene targets for therapy

✍ Robert L. Ferris 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Molecular determinants of efficacy for 5

Molecular determinants of efficacy for 5-FU-based treatments in advanced colorectal cancer: mRNA expression for 18 chemotherapy-related genes

✍ Bengt Gustavsson; Christopher Kaiser; Göran Carlsson; Yvonne Wettergren; Elisabe 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 112 KB 👁 1 views

## Abstract 5‐Fluorouracil (5‐FU)‐based regimens remain a cornerstone in the treatment of colorectal cancer (CRC). However, the attendant toxicity prevents these regimens from reaching maximum therapeutic potential. In this retrospective analysis, we examined the pretreatment expression of 18 genes